CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primar (Q38402419)
Jump to navigation
Jump to search
scientific article published on 09 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primar |
scientific article published on 09 July 2012 |
Statements
1 reference
CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primar (English)
1 reference
1 reference
Swethajit Biswas
1 reference
Philip J S Charlesworth
1 reference
Gareth D H Turner
1 reference
Russell Leek
1 reference
Paul T Thamboo
1 reference
Leticia Campo
1 reference
Helen Turley
1 reference
Petra Dildey
1 reference
Andrew Protheroe
1 reference
David Cranston
1 reference
Kevin C Gatter
1 reference
Francesco Pezzella
1 reference
9 July 2012
1 reference
1 reference
Identifiers
1 reference